Pharmaceutical company Moderna is collaborating with IBM to explore the potential of a quantum algorithm in predicting stable mRNA structures. This partnership aims to determine if quantum technology can offer more accurate predictions compared to existing methods.
Moderna, known for its development of mRNA-based vaccines, is seeking to enhance its research capabilities by leveraging IBM’s expertise in quantum computing. By utilizing a quantum algorithm, the company hopes to improve the accuracy of predicting mRNA structures, which is crucial for the development of new therapeutics.
The collaboration between Moderna and IBM underscores the growing interest in quantum computing within the healthcare and pharmaceutical industries. Quantum computing has the potential to revolutionize drug discovery and development by enabling more sophisticated simulations and analysis.
Overall, the partnership between Moderna and IBM represents a significant step towards harnessing the power of quantum computing in the field of medical research. By exploring the capabilities of quantum algorithms in predicting mRNA structures, the two companies are paving the way for future advancements in therapeutics and healthcare.
Article Source
https://www.iotworldtoday.com/health-care/ibm-moderna-partner-on-quantum-for-biotech
